Study of the Safety and Efficacy of Tropicamide Thin Films to Reduce Hypersalivation in Parkinson's Patients
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
To study the safety and efficacy of tropicamide 1 mg intra-oral slow dissolving muco-adhesive
thin films compared to placebo to reduce hypersalivation in PD patients manifesting
sialorrhea complaints.
Phase:
Phase 2
Details
Lead Sponsor:
NeuroHealing Pharmaceuticals Inc.
Collaborator:
Michael J. Fox Foundation for Parkinson's Research